SAB Biotherapeutics (SABS) Long-Term Debt Repayments (2021 - 2026)
SAB Biotherapeutics' Long-Term Debt Repayments was $37,388 in Q1 2026, up 8.0% from $34,618 a year earlier.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Long-Term Debt Repayments (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, SAB Biotherapeutics' Long-Term Debt Repayments was $278,619 through Mar 31, 2026, down 74.9% year-over-year; for FY2025, it came in at $275,849, down 78.6% from FY2024.
- Long-Term Debt Repayments shows a five-year compound annual growth rate of -27.4% (FY2020 to FY2025).
- In earlier years, Long-Term Debt Repayments was $1.29 million in FY2024 (+25.5%), $1.03 million in FY2023 (-81.4%), $5.52 million in FY2022 (+405.1%) and $1.09 million in FY2021 (-19.9%).
- Quarterly Long-Term Debt Repayments has moved between $3.00 (Q3 2025) and $3.75 million (Q4 2022) over five years.
- Compared with a year earlier, Long-Term Debt Repayments was higher in three of the last seven quarters, with growth averaging 34.9%.
- The best year-over-year quarter for Long-Term Debt Repayments over five years was Q3 2024 (growth of 450.4%); the worst was Q3 2025 (a decline of 100.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.00 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -2.45 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 17.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | SAB Biotherapeutics | 264.67 Mn | 264.67 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 37,388.00 |
| Sep 30, 2025 | 3.00 |
| Jun 30, 2025 | 241,228.00 |
| Mar 31, 2025 | 34,618.00 |
| Dec 31, 2024 | 240,133.00 |
| Sep 30, 2024 | 615,818.00 |
| Jun 30, 2024 | 219,649.00 |
| Mar 31, 2024 | 215,382.00 |
| Dec 31, 2023 | 255,989.00 |
| Sep 30, 2023 | 111,893.00 |
| Jun 30, 2023 | 332,585.00 |
| Mar 31, 2023 | 328,187.00 |
| Dec 31, 2022 | 3.75 Mn |
| Sep 30, 2022 | 254,913.00 |
| Jun 30, 2022 | 761,050.00 |
| Mar 31, 2022 | 755,783.00 |
| Dec 31, 2021 | 950,123.00 |
| Sep 30, 2021 | 51,229.00 |
| Jun 30, 2021 | 46,228.00 |
| Mar 31, 2021 | 45,471.00 |
API Access
SAB Biotherapeutics Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();